Related references
Note: Only part of the references are listed.Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer's Disease
Mingzhenlong Deng et al.
MOLECULES (2023)
Targeting neuroinflammation in Alzheimer's disease: from mechanisms to clinical applications
Zi-Zhen Si et al.
NEURAL REGENERATION RESEARCH (2023)
Detection of ?-amyloid peptide aggregates by quartz crystal microbalance based on dual-aptamer assisted signal amplification
Chenchen Wang et al.
ANALYTICA CHIMICA ACTA (2023)
Structurally Different Yet Functionally Similar: Aptamers Specific for the Ebola Virus Soluble Glycoprotein and GP1,2 and Their Application in Electrochemical Sensing
Soma Banerjee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Aptamer-Based Targeted Delivery of Functional Nucleic Acids
Sitao Xie et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2023)
Intracellular DAMPs in Neurodegeneration and Their Role in Clinical Therapeutics
Jasleen Kaur et al.
MOLECULAR NEUROBIOLOGY (2023)
Advances in the mechanisms and applications of inhibitory oligodeoxynucleotides against immune-mediated inflammatory diseases
Hongrui Wang et al.
FRONTIERS IN PHARMACOLOGY (2023)
APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic stroke
Macarena Hernandez-Jimenez et al.
FRONTIERS IN NEUROLOGY (2023)
Development of an Aptamer-Based Molecular Tool for Specifically Targeting Microglia via the CD64 Protein
Hui Zhu et al.
ANALYTICAL CHEMISTRY (2023)
Targeted immunotherapy of triple-negative breast cancer by aptamer-engineered NK cells
Zhenghu Chen et al.
BIOMATERIALS (2022)
The natural (poly)phenols as modulators of microglia polarization via TLR4/NF-κB pathway exert anti-inflammatory activity in ischemic stroke
Ruoqi Li et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2022)
Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases
Kazuma Murakami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2022)
Aptamers: Potential Diagnostic and Therapeutic Agents for Blood Diseases
Maher M. Aljohani et al.
MOLECULES (2022)
LPS-induced lipid alterations in microglia revealed by MALDI mass spectrometry-based cell fingerprinting in neuroinflammation studies
Martina Blank et al.
SCIENTIFIC REPORTS (2022)
Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function
Md Masud Alam et al.
CELL REPORTS (2022)
Microglia Polarization From M1 to M2 in Neurodegenerative Diseases
Shenrui Guo et al.
FRONTIERS IN AGING NEUROSCIENCE (2022)
NXP032 Ameliorates Aging-Induced Oxidative Stress and Cognitive Impairment in Mice through Activation of Nrf2 Signaling
Jae-Min Lee et al.
ANTIOXIDANTS (2022)
Natural Products as Novel Neuroprotective Agents; Computational Predictions of the Molecular Targets, ADME Properties, and Safety Profile
Sahar Saleh Alghamdi et al.
PLANTS-BASEL (2022)
Cytokines in the Brain and Neuroinflammation: We Didn't Starve the Fire!
Jan Pieter Konsman
PHARMACEUTICALS (2022)
Amyloid-β activates NLRP3 inflammasomes by affecting microglial immunometabolism through the Syk-AMPK pathway
Eun Sun Jung et al.
AGING CELL (2022)
Special Section on Pharmacokinetics and ADME of Biological Therapeutics-Minireview Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration-Approved Antisense Oligonucleotide Drugs
Julia M. Migliorati et al.
DRUG METABOLISM AND DISPOSITION (2022)
Research progress of whole-cell-SELEX selection and the application of cell-targeting aptamer
Yu Duan et al.
MOLECULAR BIOLOGY REPORTS (2022)
Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II
Jutta Gaertner et al.
MULTIPLE SCLEROSIS JOURNAL (2022)
Targeting complement in neurodegeneration: challenges, risks, and strategies
Wioleta M. Zelek et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2022)
Aptamers Targeting Hallmark Proteins of Neurodegeneration
Niloufar Mollasalehi et al.
NUCLEIC ACID THERAPEUTICS (2022)
General Principles Underpinning Amyloid Structure
Alexander I. P. Taylor et al.
FRONTIERS IN NEUROSCIENCE (2022)
The Aptamer Ob2, a novel AChE inhibitor, restores cognitive deficits and alleviates amyloidogenesis in 5xFAD transgenic mice
Zhiman Liang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2022)
First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers
Macarena Hernandez-Jimenez et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2022)
Strategies for Targeted Delivery of Exosomes to the Brain: Advantages and Challenges
Hojun Choi et al.
PHARMACEUTICS (2022)
Current Strategies to Enhance Delivery of Drugs across the Blood-Brain Barrier
Raluca Ioana Teleanu et al.
PHARMACEUTICS (2022)
G-quadruplex-containing oligodeoxynucleotides as DNA topoisomerase I inhibitors
Dawei Li et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)
Aptamer truncation strategy assisted by molecular docking and sensitive detection of T-2 toxin using SYBR Green I as a signal amplifier
Pengfei Ma et al.
FOOD CHEMISTRY (2022)
Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach
Jigyasha Timsina et al.
JOURNAL OF ALZHEIMERS DISEASE (2022)
The role of Toll-like receptors and neuroinflammation in Parkinson's disease
Arash Heidari et al.
JOURNAL OF NEUROINFLAMMATION (2022)
Therapeutic Potential of Different Natural Products for the Treatment of Alzheimer's Disease
Biswajit Chakraborty et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)
NXP031 prevents dopaminergic neuronal loss and oxidative damage in the AAV-WT-alpha-synuclein mouse model of Parkinson's disease
Min Kyung Song et al.
PLOS ONE (2022)
NEURODEGENERATION Elucidating the causes of neurodegeneration
Gregory A. Petsko et al.
SCIENCE (2022)
Aptamer engineering exosomes loaded on biomimetic periosteum to promote angiogenesis and bone regeneration by targeting injured nerves via JNK3 MAPK pathway
Yanlin Su et al.
MATERIALS TODAY BIO (2022)
New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer's Disease and Its Potential for Therapeutic Intervention
Tiantian Li et al.
CELLS (2022)
Aptamers as Theragnostic Tools in Prostate Cancer
Carlos David Cruz-Hernandez et al.
BIOMOLECULES (2022)
Transferrin Aptamers Increase the In Vivo Blood-Brain Barrier Targeting of Protein Spherical Nucleic Acids
Caroline D. Kusmierz et al.
BIOCONJUGATE CHEMISTRY (2022)
Glial Cell-Mediated Neuroinflammation in Alzheimer's Disease
Nour F. Al-Ghraiybah et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The brain-immune ecosystem: Implications for immunotherapy in defeating neurodegenerative diseases
Michal Schwartz et al.
NEURON (2022)
Application of aptamers in regenerative medicine
Zhaohui Luo et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)
Aptamer blocking S-TLR4 interaction selectively inhibits SARS-CoV-2 induced inflammation
Gang Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications
Shuaijian Ni et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
Aptamer Generated by Cell-SELEX for Specific Targeting of Human Glioma Cells
Ningqin Lin et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
Brain-targeted delivery of obidoxime, using aptamer-modified liposomes, for detoxification of organophosphorus compounds
Yadan Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Ubiquitin signalling in neurodegeneration: mechanisms and therapeutic opportunities
Marlene F. Schmidt et al.
CELL DEATH AND DIFFERENTIATION (2021)
An enzyme linked aptamer photoelectrochemical biosensor for Tau-381 protein using AuNPs/MoSe2 as sensing material
Xu Hun et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2021)
Novel DEK-Targeting Aptamer Delivered by a Hydrogel Microneedle Attenuates Collagen-Induced Arthritis
Jian Cao et al.
MOLECULAR PHARMACEUTICS (2021)
Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Fangda Leng et al.
NATURE REVIEWS NEUROLOGY (2021)
Neuroprotective effect of NXP031 in the MPTP-induced Parkinson's disease model
Min Kyung Song et al.
NEUROSCIENCE LETTERS (2021)
Aptamer Blocking Strategy Inhibits SARS-CoV-2 Virus Infection
Miao Sun et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Deciphering the Role of Nanoparticle-based Treatment for Parkinson's Disease
Md Marufur Rahman Moni et al.
CURRENT DRUG METABOLISM (2021)
TLR4 and AT1R mediate blood-brain barrier disruption, neuroinflammation, and autonomic dysfunction in spontaneously hypertensive rats
Francesca E. Mowry et al.
PHARMACOLOGICAL RESEARCH (2021)
Recent Advances in Aptasensor for Cytokine Detection: A Review
Jinmyeong Kim et al.
SENSORS (2021)
Minocycline promotes functional recovery in ischemic stroke by modulating microglia polarization through STAT1/STAT6 pathways
Yunnan Lu et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Delivery of oligonucleotide-based therapeutics: challenges and opportunities
Suzan M. Hammond et al.
EMBO MOLECULAR MEDICINE (2021)
Senescent Microglia: The Key to the Ageing Brain?
Eleanor K. Greenwood et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Inflammatory Cascade in Alzheimer's Disease Pathogenesis: A Review of Experimental Findings
Jade de Oliveira et al.
CELLS (2021)
Exosomes, a New Star for Targeted Delivery
Huizhi Chen et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Microglia-Derived Interleukin 23: A Crucial Cytokine in Alzheimer's Disease?
Louisa Nitsch et al.
FRONTIERS IN NEUROLOGY (2021)
Microfluidic Chip-Based Cancer Diagnosis and Prediction of Relapse by Detecting Circulating Tumor Cells and Circulating Cancer Stem Cells
Hyeon-Yeol Cho et al.
CANCERS (2021)
Microglial Pruning: Relevance for Synaptic Dysfunction in Multiple Sclerosis and Related Experimental Models
Maria Concetta Geloso et al.
CELLS (2021)
Neuroprotective Herbs for the Management of Alzheimer's Disease
Julie Gregory et al.
BIOMOLECULES (2021)
Secondary immunodeficiencies An overview
Karen S. Tuano et al.
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2021)
Circular L-RNA aptamer promotes target recognition and controls gene activity
Danyang Ji et al.
NUCLEIC ACIDS RESEARCH (2021)
Microglial morphology in Alzheimer's disease and after Aβ immunotherapy
Diana K. Franco-Bocanegra et al.
SCIENTIFIC REPORTS (2021)
Advances in aptamer screening and aptasensors' detection of heavy metal ions
Wenfei Guo et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Age-associated changes in microglia and astrocytes ameliorate blood-brain barrier dysfunction
Jie Pan et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2021)
Laser Scribing Fabrication of Graphitic Carbon Biosensors for Label-Free Detection of Interleukin-6
Pei Shee Tan et al.
NANOMATERIALS (2021)
Immunotherapies for Neurodegenerative Diseases
Ibrahim Mortada et al.
FRONTIERS IN NEUROLOGY (2021)
B Cells in Neuroinflammation: New Perspectives and Mechanistic Insights
Julie J. Ahn et al.
CELLS (2021)
Uptake mechanisms of cell-internalizing nucleic acid aptamers for applications as pharmacological agents
Samira Husen Alamudi et al.
RSC MEDICINAL CHEMISTRY (2021)
Neuromodulation by the immune system: a focus on cytokines
Andrea Francesca Salvador et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Advances in dermatology using DNA aptamer Aptamin C innovation: Oxidative stress prevention and effect maximization of vitamin C through antioxidation
Sooho Choi et al.
JOURNAL OF COSMETIC DERMATOLOGY (2020)
Therapeutic Aptamers: Evolving to Find their Clinical Niche
Shahid M. Nimjee et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Therapeutic applications of AS1411 aptamer, an update review
Rezvan Yazdian-Robati et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Aptamer-Based Targeted Drug Delivery Systems: Current Potential and Challenges
Fen He et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Minocycline treatment prevents depression and anxiety-like behaviors and promotes neuroprotection after experimental ischemic stroke
Quezya Mendes Camargos et al.
BRAIN RESEARCH BULLETIN (2020)
Dual function of interleukin-23 Aptamer to suppress brain inflammation via attachment to macrophage stimulating 1 kinase and interleukin-23
Hossein Shandadi Sardou et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2020)
Interleukin-12/23 deficiency differentially affects pathology in male and female Alzheimer's disease-like mice
Pascale Eede et al.
EMBO REPORTS (2020)
An RNA aptamer with potent affinity for a toxic dimer of amyloid?42 has potential utility for histochemical studies of Alzheimer's disease
Kazuma Murakami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Enhanced in Vivo Blood-Brain Barrier Penetration by Circular Tau-Transferrin Receptor Bifunctional Aptamer for Tauopathy Therapy
Xiaowei Li et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2020)
Advances in oral immunomodulating therapies in relapsing multiple sclerosis
Tobias Derfuss et al.
LANCET NEUROLOGY (2020)
Aptamers Chemistry: Chemical Modifications and Conjugation Strategies
Fadwa Odeh et al.
MOLECULES (2020)
Systemic factors as mediators of brain homeostasis, ageing and neurodegeneration
John Pluvinage et al.
NATURE REVIEWS NEUROSCIENCE (2020)
The biology, function, and biomedical applications of exosomes
Raghu Kalluri et al.
SCIENCE (2020)
Amyloid-beta peptide detection via aptamer-functionalized nanowire sensors exploiting single-trap phenomena
Yurii Kutovyi et al.
BIOSENSORS & BIOELECTRONICS (2020)
Inflammatory Role of TLR-MyD88 Signaling in Multiple Sclerosis
Chao Zheng et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
Zhaoying Fu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Microglia alterations in neurodegenerative diseases and their modeling with human induced pluripotent stem cell and other platforms
Angelica Maria Sabogal-Guaqueta et al.
PROGRESS IN NEUROBIOLOGY (2020)
Central and peripheral anti-inflammatory effects of acetylcholinesterase inhibitors
Shani Vaknine et al.
NEUROPHARMACOLOGY (2020)
When It Comes to an End: Oxidative Stress Crosstalk with Protein Aggregation and Neuroinflammation Induce Neurodegeneration
Patrycja Michalska et al.
ANTIOXIDANTS (2020)
Non-Invasive Delivery of Therapeutics into the Brain: The Potential of Aptamers for Targeted Delivery
Bakhtiar Bukari et al.
BIOMEDICINES (2020)
Neuroinflammation Treatment via Targeted Delivery of Nanoparticles
Susana R. Cerqueira et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2020)
Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease
Amanda McQuade et al.
NATURE COMMUNICATIONS (2020)
Role of Toll Like Receptor 4 in Alzheimer's Disease
Maria Calvo-Rodriguez et al.
FRONTIERS IN IMMUNOLOGY (2020)
Therapeutic Interventions into Innate Immune Diseases by Means of Aptamers
Farzana Yasmeen et al.
PHARMACEUTICS (2020)
Detection of Amyloid β Oligomers with RNA Aptamers in AppNL-G-F/NL-G-F Mice: A Model of Arctic Alzheimer's Disease
Yayoi Obata et al.
ACS OMEGA (2020)
Aptamer-Functionalized Nanoparticles in Targeted Delivery and Cancer Therapy
Zhaoying Fu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Development of a CD63 Aptamer for Efficient Cancer Immunochemistry and Immunoaffinity-Based Exosome Isolation
Zhenguo Song et al.
MOLECULES (2020)
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Hyuk Sung Kwon et al.
TRANSLATIONAL NEURODEGENERATION (2020)
A blood-brain barrier overview on structure, function, impairment, and biomarkers of integrity
Hossam Kadry et al.
FLUIDS AND BARRIERS OF THE CNS (2020)
Anti-inflammatories in Alzheimer's disease-potential therapy or spurious correlate?
Jack Rivers-Auty et al.
BRAIN COMMUNICATIONS (2020)
Neuroinflammation Mechanisms and Phytotherapeutic Intervention: A Systematic Review
Navrinder Kaur et al.
ACS CHEMICAL NEUROSCIENCE (2020)
DEK-targeting aptamer DTA-64 attenuates bronchial EMT-mediated airway remodelling by suppressing TGF-β1/Smad, MAPK and PI3K signalling pathway in asthma
Yilan Song et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
The Evolving Dialogue of Microglia and Neurons in Alzheimer's Disease: Microglia as Necessary Transducers of Pathology
E. Simon et al.
NEUROSCIENCE (2019)
Emerging pathways to neurodegeneration: Dissecting the critical molecular mechanisms in Alzheimer's disease, Parkinson's disease
Sean Hong Tan et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
The benefits of neuroinflammation for the repair of the injured central nervous system
Heather Y. F. Yong et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2019)
An exploration of aptamer internalization mechanisms and their applications in drug delivery
Lin-Yan Wan et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution
Takahiro Masuda et al.
NATURE (2019)
Analyzing Secondary Structure Patterns in DNA Aptamers Identified via CompELS
Richard Sullivan et al.
MOLECULES (2019)
Single-Cell Transcriptomics Analyses of Neural Stem Cell Heterogeneity and Contextual Plasticity in a Zebrafish Brain Model of Amyloid Toxicity
Mehmet Ilyas Cosacak et al.
CELL REPORTS (2019)
The Evolving Role of CD8+CD28- Immunosenescent T Cells in Cancer Immunology
Wei X. Huff et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Toll-like receptors in the pathogenesis of neuroinflammation
V Kumar
JOURNAL OF NEUROIMMUNOLOGY (2019)
Central nervous system regeneration is driven by microglia necroptosis and repopulation
Amy F. Lloyd et al.
NATURE NEUROSCIENCE (2019)
Neuroinflammation - a common thread in neurological disorders
Nils Erik Gilhus et al.
NATURE REVIEWS NEUROLOGY (2019)
Targeting microglia in brain disorders
Josef Priller et al.
SCIENCE (2019)
Exosomal DNA Aptamer Targeting α-Synuclein Aggregates Reduced Neuropathological Deficits in a Mouse Parkinson's Disease Model
Xiaoxi Ren et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
A General Introduction to Glucocorticoid Biology
Steven Timmermans et al.
FRONTIERS IN IMMUNOLOGY (2019)
Aptamer-Conjugated Framework Nucleic Acids for the Repair of Cerebral Ischemia-Reperfusion Injury
Shiyong Li et al.
NANO LETTERS (2019)
The BACE1-Specific DNA Aptamer A1 Rescues Amyloid-β Pathology and Behavioral Deficits in a Mouse Model of Alzheimer's Disease
Zhi-Man Liang et al.
NUCLEIC ACID THERAPEUTICS (2019)
Heat-Shock Proteins in Neuroinflammation
Brigitta Dukay et al.
FRONTIERS IN PHARMACOLOGY (2019)
Neuroinflammation as a Common Feature of Neurodegenerative Disorders
Leonardo Guzman-Martinez et al.
FRONTIERS IN PHARMACOLOGY (2019)
Inside the Black Box: What Makes SELEX Better?
Natalia Komarova et al.
MOLECULES (2019)
Microglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology
Sofie Voet et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Thermodynamic study of aptamers binding to their target proteins
Taiichi Sakamoto et al.
BIOCHIMIE (2018)
Selective drug delivery approaches to lesioned brain through blood brain barrier disruption
Zahraa S. Al-Ahmady
EXPERT OPINION ON DRUG DELIVERY (2018)
Inflammation in CNS neurodegenerative diseases
Jodie Stephenson et al.
IMMUNOLOGY (2018)
Differential protein expression of hippocampal cells associated with heavy metals (Pb, As, and MeHg) neurotoxicity: Deepening into the molecular mechanism of neurodegenerative diseases
Venkatanaidu Karri et al.
JOURNAL OF PROTEOMICS (2018)
Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease
Srikant Rangaraju et al.
MOLECULAR NEURODEGENERATION (2018)
Mechanisms of clathrin-mediated endocytosis
Marko Kaksonen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)
Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Melanie D. Sweeney et al.
NATURE REVIEWS NEUROLOGY (2018)
Doxycycline counteracts neuroinflammation restoring memory in Alzheimer's disease mouse models
Claudia Balducci et al.
NEUROBIOLOGY OF AGING (2018)
Emerging Paradigm of Intracellular Targeting of G Protein-Coupled Receptors
Madhu Chaturvedi et al.
TRENDS IN BIOCHEMICAL SCIENCES (2018)
NSAID Exposure and Risk of Alzheimer's Disease: An Updated Meta-Analysis From Cohort Studies
Caixia Zhang et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Anti-neuroinflammatory Potential of Natural Products in Attenuation of Alzheimer's Disease
Bushra Shal et al.
FRONTIERS IN PHARMACOLOGY (2018)
Novel DNA Aptamers for Parkinson's Disease Treatment Inhibit alpha-Synuclein Aggregation and Facilitate its Degradation
Yuan Zheng et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
A Synthetic Cross-Species CD200R1 Agonist Suppresses Inflammatory Immune Responses In Vivo
Aaron Prodeus et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Aptamer-based targeted therapy
Guizhi Zhu et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Denzil Furtado et al.
ADVANCED MATERIALS (2018)
SELEX methods on the road to protein targeting with nucleic acid aptamers
Payam Bayat et al.
BIOCHIMIE (2018)
Microglia Response During Parkinson's Disease: Alpha-Synuclein Intervention
Sara A. Ferreira et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Damage-Associated Molecular Patterns in Inflammatory Diseases
Jong Seong Roh et al.
IMMUNE NETWORK (2018)
Neuroprotective Mechanisms of Resveratrol in Alzheimer's Disease: Role of SIRT1
Bruno Alexandre Quadros Gomes et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
Role of Microglia TLRs in Neurodegeneration
Bernd L. Fiebich et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Possible strategies to cross the blood-brain barrier
Cinzia M. Bellettato et al.
ITALIAN JOURNAL OF PEDIATRICS (2018)
Potential Inherent Stimulation of the Innate Immune System by Nucleic Acid Aptamers and Possible Corrective Approaches
John G. Bruno
PHARMACEUTICALS (2018)
Necroptosis in microglia contributes to neuroinflammation and retinal degeneration through TLR4 activation
Zijing Huang et al.
CELL DEATH AND DIFFERENTIATION (2018)
Aptamers Against Pro- and Anti-Inflammatory Cytokines: A Review
Maryam Boshtam et al.
INFLAMMATION (2017)
Neuroinflammation pathways: a general review
Tara Shabab et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2017)
Inflammatory Response in the CNS: Friend or Foe?
Marta Sochocka et al.
MOLECULAR NEUROBIOLOGY (2017)
Aptamers as targeted therapeutics: current potential and challenges
Jiehua Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Reactive Astrocytes: Production, Function, and Therapeutic Potential
Shane A. Liddelow et al.
IMMUNITY (2017)
Natalizumab in Multiple Sclerosis: Long-Term Management
Marinella Clerico et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes
Shuaijian Ni et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Inhibiting the microglia activation improves the spatial memory and adult neurogenesis in rat hippocampus during 48 h of sleep deprivation
Meetu Wadhwa et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides
Chunsong Yu et al.
MOLECULAR PHARMACEUTICS (2017)
Rapid Complexation of Aptamers by Their Specific Antidotes
Heidi Stoll et al.
MOLECULES (2017)
Selective neuronal vulnerability in Parkinson disease
D. James Surmeier et al.
NATURE REVIEWS NEUROSCIENCE (2017)
Neuroimmunology of Traumatic Brain Injury: Time for a ParadigmShift
Yasir N. Jassam et al.
NEURON (2017)
DEK-targeting DNA aptamers as therapeutics for inflammatory arthritis
Nirit Mor-Vaknin et al.
NATURE COMMUNICATIONS (2017)
The Lifespan and Turnover of Microglia in the Human Brain
Pedro Reu et al.
CELL REPORTS (2017)
Coupled Proliferation and Apoptosis Maintain the Rapid Turnover of Microglia in the Adult Brain
Katharine Askew et al.
CELL REPORTS (2017)
Assessment of Variability in the SOMAscan Assay
Julian Candia et al.
SCIENTIFIC REPORTS (2017)
Cytokine networks in neuroinflammation
Burkhard Becher et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Molecular-based diagnosis of multiple sclerosis and its progressive stage
Christopher Barbour et al.
ANNALS OF NEUROLOGY (2017)
Amyloid beta: structure, biology and structure-based therapeutic development
Guo-fang Chen et al.
ACTA PHARMACOLOGICA SINICA (2017)
Resveratrol regulates microglia M1/M2 polarization via PGC-1α in conditions of neuroinflammatory injury
Xiaodong Yang et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Delivery is key: lessons learnt from developing splice-switching antisense therapies
Caroline Godfrey et al.
EMBO MOLECULAR MEDICINE (2017)
Development of a Bifunctional Aptamer Targeting the Transferrin Receptor and Epithelial Cell Adhesion Molecule (EpCAM) for the Treatment of Brain Cancer Metastases
Joanna Macdonald et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Is amyloid-beta harmful to the brain? Insights from human imaging studies
William Jagust
BRAIN (2016)
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
Yu Tang et al.
MOLECULAR NEUROBIOLOGY (2016)
Hippo/MST1 signaling mediates microglial activation following acute cerebral ischemia-reperfusion injury
Siqi Zhao et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Long-term side effects of glucocorticoids
Merih Oray et al.
EXPERT OPINION ON DRUG SAFETY (2016)
Neuroinflammation: the devil is in the details
Damon J. DiSabato et al.
JOURNAL OF NEUROCHEMISTRY (2016)
New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies
T. Sehr et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Brain trauma elicits non-canonical macrophage activation states
Charles C. Kim et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial
A. Michael Lincoff et al.
LANCET (2016)
INHIBITION OF CEREBRAL VASCULAR INFLAMMATION BY BRAIN ENDOTHELIUM-TARGETED OLIGODEOXYNUCLEOTIDE COMPLEX
Jing Hu et al.
NEUROSCIENCE (2016)
Cytokine Therapies in Neurological Disease
Shila Azodi et al.
NEUROTHERAPEUTICS (2016)
Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models
Michael J. D. Daniels et al.
NATURE COMMUNICATIONS (2016)
A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor Effects
Wei-Yun Lai et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2016)
Bioactivity of 2′-deoxyinosine-incorporated aptamer AS1411
Xinmeng Fan et al.
SCIENTIFIC REPORTS (2016)
Development of Cell-SELEX Technology and Its Application in Cancer Diagnosis and Therapy
Man Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Aptamer-Drug Conjugates
Guizhi Zhu et al.
BIOCONJUGATE CHEMISTRY (2015)
Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial
Joseph Butchart et al.
NEUROLOGY (2015)
RNA Structures as Mediators of Neurological Diseases and as Drug Targets
Viachaslau Bernat et al.
NEURON (2015)
Neuroinflammation: Ways in Which the Immune System Affects the Brain
Richard M. Ransohoff et al.
NEUROTHERAPEUTICS (2015)
Inhibition of BACE1 Activity by a DNA Aptamer in an Alzheimer's Disease Cell Model
Huiyu Liang et al.
PLOS ONE (2015)
Minocycline reduces neuroinflammation but does not ameliorate neuron loss in a mouse model of neurodegeneration
Shanshan Cheng et al.
SCIENTIFIC REPORTS (2015)
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
Mark D. Turner et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization
Julia Hoellenriegel et al.
BLOOD (2014)
Current approaches to enhance CNS delivery of drugs across the brain barriers
Cui-Tao Lu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease
Zhiyou Cai et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2014)
A phase II trial of AS1411 (a novel nucleolin-targeted DNA aptamer) in metastatic renal cell carcinoma
Jonathan E. Rosenberg et al.
INVESTIGATIONAL NEW DRUGS (2014)
Stage-Dependent Nigral Neuronal Loss in Incidental Lewy Body and Parkinson's Disease
Anke A. Dijkstra et al.
MOVEMENT DISORDERS (2014)
Binding of an RNA aptamer and a partial peptide of a prion protein: crucial importance of water entropy in molecular recognition
Tomohiko Hayashi et al.
NUCLEIC ACIDS RESEARCH (2014)
Cognitive effects of a dietary supplement made from extract of Bacopa monnieri, astaxanthin, phosphatidylserine, and vitamin E in subjects with mild cognitive impairment: a noncomparative, exploratory clinical study
Danilo Zanotta et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
Agonistic CD200R1 DNA Aptamers Are Potent Immunosuppressants That Prolong Allogeneic Skin Graft Survival
Aaron Prodeus et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2014)
The epigenetics of multiple sclerosis and other related disorders
Peter J. van den Elsen et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2014)
A comparative review of toll-like receptor 4 expression and functionality in different animal species
Celine Vaure et al.
FRONTIERS IN IMMUNOLOGY (2014)
A Short DNA Aptamer That Recognizes TNFα and Blocks Its Activity in Vitro
Erik W. Orava et al.
ACS CHEMICAL BIOLOGY (2013)
Brain injury biomarkers are not dependent on -amyloid in normal elderly
David S. Knopman et al.
ANNALS OF NEUROLOGY (2013)
The role of Gliadel wafers in the treatment of high-grade gliomas
Amade Bregy et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2013)
In vitro selection of a DNA aptamer targeted against Shigella dysenteriae
Nuo Duan et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2013)
Microglia: Scapegoat, Saboteur, or Something Else?
Adriano Aguzzi et al.
SCIENCE (2013)
Minocycline selectively inhibits M1 polarization of microglia
K. Kobayashi et al.
CELL DEATH & DISEASE (2013)
In vivo SELEX for Identification of Brain-penetrating Aptamers
Congsheng Cheng et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Single-molecule atomic force microscopy on live cells compares aptamer and antibody rupture forces
Meghan B. O'Donoghue et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2012)
Selection of DNA Aptamers That Recognize α-Synuclein Oligomers Using a Competitive Screening Method
Kaori Tsukakoshi et al.
ANALYTICAL CHEMISTRY (2012)
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury
Christer Baeck et al.
GUT (2012)
Gene expression profiling in human neurodegenerative disease
Johnathan Cooper-Knock et al.
NATURE REVIEWS NEUROLOGY (2012)
Examining the mechanisms that link beta-amyloid and alpha-synuclein pathologies
Samuel E. Marsh et al.
ALZHEIMERS RESEARCH & THERAPY (2012)
An RNA Alternative to Human Transferrin: A New Tool for Targeting Human Cells
Samantha E. Wilner et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2012)
Cell-SELEX Technology
Shoji Ohuchi
BIORESEARCH OPEN ACCESS (2012)
Bioavailability of resveratrol
Thomas Walle
RESVERATROL AND HEALTH (2011)
The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights
Agnes E. Coutinho et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Molecular mechanism and physiological functions of clathrin-mediated endocytosis
Harvey T. McMahon et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Mechanisms Underlying Inflammation in Neurodegeneration
Christopher K. Glass et al.
CELL (2010)
Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke
Jin A. Shin et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
The emerging field of RNA nanotechnology
Peixuan Guo
NATURE NANOTECHNOLOGY (2010)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Florent Ginhoux et al.
SCIENCE (2010)
Non-Steroidal Anti-Inflammatory Drugs in Alzheimer's Disease and Parkinson's Disease: Reconsidering the Role of Neuroinflammation
Amy H. Moore et al.
PHARMACEUTICALS (2010)
Non-Steroidal Anti-Inflammatory Drugs and Brain Inflammation: Effects on Microglial Functions
Maria Antonietta Ajmone-Cat et al.
PHARMACEUTICALS (2010)
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Joerg Vollmer et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Mechanisms of Endocytosis
Gary J. Doherty et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
An update on the efficacy of non-steroidal anti-inflammatory drugs in Alzheimer's disease
Bruno P. Imbimbo
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
Erin E. Longbrake et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2009)
Identification and characterization of oligonucleotides that inhibit Toll-like receptor 2-associated immune responses
Yi-Chung Chang et al.
FASEB JOURNAL (2009)
Molecular recognition of acute myeloid leukemia using aptamers
K. Sefah et al.
LEUKEMIA (2009)
Multivalent 4-1BB binding aptamers costimulate CD8(+) T cells and inhibit tumor growth in mice
James O. McNamara et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Exploring TAR-RNA aptamer loop-loop interaction by X-ray crystallography, UV spectroscopy and surface plasmon resonance
Isabelle Lebars et al.
NUCLEIC ACIDS RESEARCH (2008)
Aptamer-based endocytosis of a lysosomal enzyme
Chi-hong B. Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Glucocorticoids in the control of neuroinflammation
Denise Tischner et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
Perispinal etanercept for treatment of Alzheimer's disease
Edward Tobinick
CURRENT ALZHEIMER RESEARCH (2007)
Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity:: role of tumor necrosis factor-α
K Sriram et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Inhibitory effect of minocycline on amyloid β fibril formation and human microglial activation
A Familian et al.
GLIA (2006)
The LPS receptor, CD14 in experimental autoimmune encephalomyelitis and multiple sclerosis
S Walter et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2006)
Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain
J Kreuter
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2004)
Pharmacokinetics and biodistribution of novel aptamer compositions
JM Healy et al.
PHARMACEUTICAL RESEARCH (2004)
Expression of CD137 and its ligand in human neurons, astrocytes, and microglia: Modulation by FGF-2
C Reali et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Broad expression of Toll-like receptors in the human central nervous system
M Bsibsi et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2002)
Oxidants, oxidative stress and the biology of ageing
T Finkel et al.
NATURE (2000)
Tetracycline affects abnormal properties of synthetic PrP peptides and PrPSc in vitro
F Tagliavini et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)